Cost-Effectiveness of Transfers to Centers With Neurological Intensive Care Units After Intracerebral Hemorrhage

被引:31
作者
Fletcher, Jeffrey J. [1 ,6 ]
Kotagal, Vikas [2 ]
Mammoser, Aaron [2 ]
Peterson, Mark [4 ]
Morgenstern, Lewis B. [1 ,3 ,5 ]
Burke, James F. [5 ]
机构
[1] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Stroke Program, Ann Arbor, MI 48109 USA
[6] Bronson Methodist Hosp, Dept Neurol, Kalamazoo, MI USA
关键词
cerebral hemorrhage; cost-effectiveness; mortality; INDUCED MOVEMENT THERAPY; PLASMINOGEN-ACTIVATOR; NEUROCRITICAL CARE; EARLY MANAGEMENT; ISCHEMIC-STROKE; OUTCOMES; ASSOCIATION; GUIDELINES; PROFESSIONALS; SPECIALTY;
D O I
10.1161/STROKEAHA.114.006653
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Our aim was to estimate the cost-effectiveness of transferring patients with intracerebral hemorrhage from centers without specialized neurological intensive care units (neuro-ICUs) to centers with neuro-ICUs. Methods-Decision analytic models were developed for the lifetime horizons. Model inputs were derived from the best available data, informed by a variety of previous cost-effectiveness models of stroke. The effect of neuro-ICU care on functional outcomes was modeled in 3 scenarios. A favorable outcomes scenario was modeled based on the best observational data and compared with moderately favorable and least-favorable outcomes scenarios. Health benefits were measured in quality-adjusted life years (QALYs), and costs were estimated from a societal perspective. Costs were combined with QALYs gained to generate incremental cost-effectiveness ratios. One-way sensitivity analysis and Monte Carlo simulations were performed to test robustness of the model assumptions. Results-Transferring patients to centers with neuro-ICUs yielded an incremental cost-effectiveness ratio for the lifetime horizon of $47431 per QALY, $91674 per QALY, and $380358 per QALY for favorable, moderately favorable, and least-favorable scenarios, respectively. Models were robust at a willingness-to-pay threshold of $100000 per QALY, with 95.5%, 75.0%, and 2.1% of simulations below the threshold for favorable, moderately favorable, and least-favorable scenarios, respectively. Conclusions-Transferring patients with intracerebral hemorrhage to centers with specialized neuro-ICUs is cost-effective if observational estimates of the neuro-ICU-based functional outcome distribution are accurate. If future work confirms these functional outcome distributions, then a strong societal rationale exists to build systems of care designed to transfer intracerebral hemorrhage patients to specialized neuro-ICUs.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 38 条
  • [1] Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups
    Adams, Harold P., Jr.
    del Zoppo, Gregory
    Alberts, Mark J.
    Bhatt, Deepak L.
    Brass, Lawrence
    Furlan, Anthony
    Grubb, Robert L.
    Higashida, Randall T.
    Jauch, Edward C.
    Kidwell, Chelsea
    Lyden, Patrick D.
    Morgenstern, Lewis B.
    Qureshi, Adnan I.
    Rosenwasser, Robert H.
    Scott, Phillip A.
    Wijdicks, Eelco F. M.
    [J]. STROKE, 2007, 38 (05) : 1655 - 1711
  • [2] Is ED disposition associated with intracerebral hemorrhage mortality?
    Adeoye, Opeolu
    Haverbusch, Mary
    Woo, Daniel
    Sekar, Padmini
    Moomaw, Charles J.
    Kleindorfer, Dawn
    Stettler, Brian
    Kissela, Brett M.
    Broderick, Joseph P.
    Flaherty, Matthew L.
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2011, 29 (04) : 391 - 395
  • [3] Recent trends in the treatment of spontaneous intracerebral hemorrhage: analysis of a nationwide inpatient database Clinical article
    Andaluz, Norberto
    Zuccarello, Mario
    [J]. JOURNAL OF NEUROSURGERY, 2009, 110 (03) : 403 - 410
  • [4] Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals
    Bardach, NS
    Zhao, SJ
    Gress, DR
    Lawton, MT
    Johnston, SC
    [J]. STROKE, 2002, 33 (07) : 1851 - 1856
  • [5] Differences in Outcome and Predictors Between Ischemic and Intracerebral Hemorrhage The South London Stroke Register
    Bhalla, Ajay
    Wang, Yanzhong
    Rudd, Anthony
    Wolfe, Charles D. A.
    [J]. STROKE, 2013, 44 (08) : 2174 - 2181
  • [6] Association Between Disability Measures and Short-term Health Care Costs Following Intracerebral Hemorrhage
    Christensen, Michael C.
    Morris, Stephen
    [J]. NEUROCRITICAL CARE, 2008, 9 (03) : 313 - 318
  • [7] Executive Summary: Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
    Connolly, E. Sander, Jr.
    Rabinstein, Alejandro A.
    Carhuapoma, J. Ricardo
    Derdeyn, Colin P.
    Dion, Jacques
    Higashida, Randall T.
    Hoh, Brian L.
    Kirkness, Catherine J.
    Naidech, Andrew M.
    Ogilvy, Christopher S.
    Patel, Aman B.
    Thompson, B. Gregory
    Vespa, Paul
    [J]. STROKE, 2012, 43 (06) : 1711 - 1737
  • [8] Admission to a neurologic/neurosurgical intensive cave unit is associated with reduced mortality rate after intracerebral hemorrhage
    Diringer, MN
    Edwards, DF
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (03) : 635 - 640
  • [9] Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage
    Earnshaw, Stephanie R.
    Joshi, Ashish V.
    Wilson, Michele R.
    Rosand, Jonathan
    [J]. STROKE, 2006, 37 (11) : 2751 - 2758
  • [10] Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke
    Fagan, SC
    Morgenstern, LB
    Petitta, A
    Ward, RE
    Tilley, BC
    Marler, JR
    Levine, SR
    Broderick, JP
    Kwiatkowski, TG
    Frankel, M
    Brott, TG
    Walker, MD
    [J]. NEUROLOGY, 1998, 50 (04) : 883 - 890